Recruiting
Friedreich's ataxia
RecruitingLong-term safety and effectiveness study of vatiquinone (oral capsules) in patients with Friedreich ataxia who have previously received this treatment
InvestigationalNo placebo
Long-term safety and effectiveness study of vatiquinone (oral capsules) in patients with Friedreich ataxia who have previously received this treatment
InvestigationalNo placebo
- Disease:Friedreich's ataxia
- Substances:Vatiquinone
Countries:
France
France- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Vatiquinone



